Skip to content

Search for:

BioToChina.org is the first organization to connect Pharma, Biotech & Medtech BDs in China and the rest of the world.

ACCESS CHINA
- 药通中国
- Organiser
  - 主办方
  - 参会报名
ACCESS ASIA BD Forum @ JPM 2026
Agenda
Register
Book 1-1 Meetings
Attendees

Tag: entertainment

YAFO Client | Breakthrough for Next-Generation TRK Inhibitor: Jiangsu Vcare’s New Anti-tumor Drug, Eratrectinib (VC004) Capsules, Receives NDA Acceptance

by biotochina14th July 2025

Continue Reading

BioToChina.org is the first organization to connect Pharma, Biotech & Medtech BDs in China and the rest of the world.

Powered by Tech-Discovery

Blog at WordPress.com.

Subscribe Subscribed
- BioToChina.org
- Already have a WordPress.com account? Log in now.